vs
CVRx, Inc.（CVRX）与林德（LIN）财务数据对比。点击上方公司名可切换其他公司
CVRx, Inc.的季度营收约是林德的1.8倍（$16.0M vs $8.8M），林德同比增速更快（8.2% vs 4.4%），林德自由现金流更多（$898.0K vs $-9.8M），过去两年CVRx, Inc.的营收复合增速更高（22.0% vs -96.7%）
CVRx, Inc.是一家处于商业化阶段的医疗科技企业，专注于慢性心血管疾病神经调节疗法的研发与商业化，旗舰产品Barostim系统用于治疗心力衰竭和难治性高血压，核心市场覆盖北美、欧洲，服务对常规药物治疗应答不佳的患者。
林德是全球知名跨国化工企业，按市场份额及营收计为全球最大工业气体供应商。公司1879年由德国科学家、工程师卡尔·冯·林德在德国威斯巴登创立，现总部位于英国沃金，在爱尔兰注册，2018年由原林德股份公司与1907年在美国成立的普莱克斯合并组建。
CVRX vs LIN — 直观对比
营收规模更大
CVRX
是对方的1.8倍
$8.8M
营收增速更快
LIN
高出3.8%
4.4%
自由现金流更多
LIN
多$10.7M
$-9.8M
两年增速更快
CVRX
近两年复合增速
-96.7%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $16.0M | $8.8M |
| 净利润 | $-11.9M | — |
| 毛利率 | 86.3% | 48.5% |
| 营业利润率 | -69.8% | 27.8% |
| 净利率 | -74.5% | — |
| 营收同比 | 4.4% | 8.2% |
| 净利润同比 | -12.0% | — |
| 每股收益（稀释后） | $-0.45 | $3.98 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CVRXLIN
| Q1 26 | — | $8.8M | ||
| Q4 25 | $16.0M | $8.8B | ||
| Q3 25 | $14.7M | $8.6B | ||
| Q2 25 | $13.6M | $8.5B | ||
| Q1 25 | $12.3M | $8.1B | ||
| Q4 24 | $15.3M | $8.3B | ||
| Q3 24 | $13.4M | $8.4B | ||
| Q2 24 | $11.8M | $8.3B |
净利润CVRXLIN
| Q1 26 | — | — | ||
| Q4 25 | $-11.9M | $1.5B | ||
| Q3 25 | $-12.9M | $1.9B | ||
| Q2 25 | $-14.7M | $1.8B | ||
| Q1 25 | $-13.8M | $1.7B | ||
| Q4 24 | $-10.7M | $1.7B | ||
| Q3 24 | $-13.1M | $1.6B | ||
| Q2 24 | $-14.0M | $1.7B |
毛利率CVRXLIN
| Q1 26 | — | 48.5% | ||
| Q4 25 | 86.3% | — | ||
| Q3 25 | 86.8% | — | ||
| Q2 25 | 84.3% | — | ||
| Q1 25 | 83.5% | — | ||
| Q4 24 | 83.2% | — | ||
| Q3 24 | 83.2% | — | ||
| Q2 24 | 83.9% | — |
营业利润率CVRXLIN
| Q1 26 | — | 27.8% | ||
| Q4 25 | -69.8% | 23.0% | ||
| Q3 25 | -83.5% | 27.5% | ||
| Q2 25 | -105.8% | 27.7% | ||
| Q1 25 | -108.8% | 26.9% | ||
| Q4 24 | -67.0% | 27.4% | ||
| Q3 24 | -97.3% | 25.0% | ||
| Q2 24 | -118.3% | 26.4% |
净利率CVRXLIN
| Q1 26 | — | — | ||
| Q4 25 | -74.5% | 17.5% | ||
| Q3 25 | -87.6% | 22.4% | ||
| Q2 25 | -108.4% | 20.8% | ||
| Q1 25 | -111.5% | 20.6% | ||
| Q4 24 | -69.4% | 20.8% | ||
| Q3 24 | -98.0% | 18.5% | ||
| Q2 24 | -118.8% | 20.1% |
每股收益（稀释后）CVRXLIN
| Q1 26 | — | $3.98 | ||
| Q4 25 | $-0.45 | $3.28 | ||
| Q3 25 | $-0.49 | $4.09 | ||
| Q2 25 | $-0.57 | $3.73 | ||
| Q1 25 | $-0.53 | $3.51 | ||
| Q4 24 | $-0.39 | $3.61 | ||
| Q3 24 | $-0.57 | $3.22 | ||
| Q2 24 | $-0.65 | $3.44 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $75.7M | $4.0M |
| 总债务越低越好 | — | $24.7M |
| 股东权益账面价值 | $39.3M | $40.1M |
| 总资产 | $104.8M | $86.3M |
| 负债/权益比越低杠杆越低 | — | 0.62× |
8季度趋势，按日历期对齐
现金及短期投资CVRXLIN
| Q1 26 | — | $4.0M | ||
| Q4 25 | $75.7M | $5.1B | ||
| Q3 25 | $85.1M | $4.5B | ||
| Q2 25 | $95.0M | $4.8B | ||
| Q1 25 | $102.7M | $5.3B | ||
| Q4 24 | $105.9M | $4.8B | ||
| Q3 24 | $100.2M | $5.2B | ||
| Q2 24 | $70.4M | $4.6B |
总债务CVRXLIN
| Q1 26 | — | $24.7M | ||
| Q4 25 | — | $20.7B | ||
| Q3 25 | — | $18.6B | ||
| Q2 25 | — | $19.7B | ||
| Q1 25 | — | $17.6B | ||
| Q4 24 | — | $15.3B | ||
| Q3 24 | — | $17.5B | ||
| Q2 24 | — | $16.9B |
股东权益CVRXLIN
| Q1 26 | — | $40.1M | ||
| Q4 25 | $39.3M | $38.2B | ||
| Q3 25 | $48.1M | $38.6B | ||
| Q2 25 | $57.9M | $38.5B | ||
| Q1 25 | $71.1M | $38.0B | ||
| Q4 24 | $71.1M | $38.1B | ||
| Q3 24 | $65.2M | $39.2B | ||
| Q2 24 | $55.2M | $38.2B |
总资产CVRXLIN
| Q1 26 | — | $86.3M | ||
| Q4 25 | $104.8M | $86.8B | ||
| Q3 25 | $111.3M | $86.0B | ||
| Q2 25 | $119.6M | $86.1B | ||
| Q1 25 | $129.6M | $82.7B | ||
| Q4 24 | $133.4M | $80.1B | ||
| Q3 24 | $127.7M | $82.5B | ||
| Q2 24 | $96.0M | $80.2B |
负债/权益比CVRXLIN
| Q1 26 | — | 0.62× | ||
| Q4 25 | — | 0.54× | ||
| Q3 25 | — | 0.48× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | 0.46× | ||
| Q4 24 | — | 0.40× | ||
| Q3 24 | — | 0.45× | ||
| Q2 24 | — | 0.44× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-9.8M | — |
| 自由现金流经营现金流 - 资本支出 | $-9.8M | $898.0K |
| 自由现金流率自由现金流/营收 | -61.3% | 10.2% |
| 资本支出强度资本支出/营收 | 0.4% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-40.8M | $4.2B |
8季度趋势，按日历期对齐
经营现金流CVRXLIN
| Q1 26 | — | — | ||
| Q4 25 | $-9.8M | $3.0B | ||
| Q3 25 | $-9.7M | $2.9B | ||
| Q2 25 | $-7.9M | $2.2B | ||
| Q1 25 | $-12.8M | $2.2B | ||
| Q4 24 | $-8.0M | $2.8B | ||
| Q3 24 | $-10.4M | $2.7B | ||
| Q2 24 | $-9.8M | $1.9B |
自由现金流CVRXLIN
| Q1 26 | — | $898.0K | ||
| Q4 25 | $-9.8M | $1.6B | ||
| Q3 25 | $-10.0M | $1.7B | ||
| Q2 25 | $-8.0M | $954.0M | ||
| Q1 25 | $-12.9M | $891.0M | ||
| Q4 24 | $-8.1M | $1.6B | ||
| Q3 24 | $-10.4M | $1.7B | ||
| Q2 24 | $-10.2M | $796.0M |
自由现金流率CVRXLIN
| Q1 26 | — | 10.2% | ||
| Q4 25 | -61.3% | 17.9% | ||
| Q3 25 | -68.1% | 19.4% | ||
| Q2 25 | -59.2% | 11.2% | ||
| Q1 25 | -104.3% | 11.0% | ||
| Q4 24 | -52.5% | 18.8% | ||
| Q3 24 | -78.1% | 19.9% | ||
| Q2 24 | -86.3% | 9.6% |
资本支出强度CVRXLIN
| Q1 26 | — | — | ||
| Q4 25 | 0.4% | 16.6% | ||
| Q3 25 | 2.0% | 14.8% | ||
| Q2 25 | 0.8% | 14.8% | ||
| Q1 25 | 0.9% | 15.7% | ||
| Q4 24 | 0.3% | 15.1% | ||
| Q3 24 | 0.3% | 12.8% | ||
| Q2 24 | 3.0% | 13.7% |
现金转化率CVRXLIN
| Q1 26 | — | — | ||
| Q4 25 | — | 1.98× | ||
| Q3 25 | — | 1.53× | ||
| Q2 25 | — | 1.25× | ||
| Q1 25 | — | 1.29× | ||
| Q4 24 | — | 1.63× | ||
| Q3 24 | — | 1.76× | ||
| Q2 24 | — | 1.16× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CVRX
| US | $14.9M | 93% |
| Other | $1.1M | 7% |
LIN
暂无分部数据
